Search
Search Results
-
HPV testing in Polish population-based cervical cancer screening programme (HIPPO project)—study protocol of a randomised healthcare policy trial
BackgroundAn Organised Cervical Cancer Screening Programme (OCCSP) was started in Poland in 2006/2007. Each woman aged 25 to 59 is eligible for a...
-
HPV positivity status in males is related to the acquisition of HPV infection in females in heterosexual couples
PurposeFew studies have focused on the impact of human papillomavirus (HPV) positivity in male partners on female HPV infection and cervical lesions....
-
Incidence of oncogenic HPV and HPV-related dysplasia five years after a negative HPV test by self-sampling in elderly women
PurposeCervical cancer prevention for older women can be challenging since there are no specific guidelines for this group . This study aimed to...
-
Differential long-term bivalent HPV vaccine cross-protection by variants in the Costa Rica HPV vaccine trial
The AS04-adjuvanted human papillomavirus (HPV)16/18 vaccine, an L1-based vaccine, provides strong vaccine efficacy (VE) against vaccine-targeted type...
-
Comparison of the AmpFire® Multiplex HPV Assay to the Xpert® HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: a pragmatic performance evaluation
BackgroundLow- and middle-income countries (LMICs) account for nearly 85% of the global cervical cancer burden, yet have the least access to...
-
A SEER-based analysis of trends in HPV-associated oropharyngeal squamous cell carcinoma
BackgroundThe proportional trends of HPV-associated oropharyngeal squamous cell carcinoma (OPSCC) according to various factors have not been analyzed...
-
Navigating therapeutic strategies: HPV classification in head and neck cancer
The World Health Organisation recognised human papillomavirus (HPV) as the cause of multiple cancers, including head and neck cancers. HPV is a...
-
Knowledge of Human Papillomavirus (HPV), Attitudes, and Practices Towards Anti-HPV Vaccination Among Israeli Nurses
Human papillomavirus (HPV) is a small, non-enveloped, double-stranded DNA virus, belonging to the family of Papillomaviridae . It is a highly common...
-
Community-Based Interventions for HPV Vaccination
Multiple disparities exist in human papillomavirus (HPV)-related cancers and HPV vaccination series initiation and completion in the USA. This...
-
Comparison of the ScreenFire and Xpert HPV assays for the detection of human papillomavirus and cervical precancer among women living with HIV in Malawi
BackgroundThe World Health Organization recommends human papillomavirus (HPV) testing for primary cervical cancer screening, including among women...
-
HPV self-sampling among women in the United States: preferences for implementation
PurposeWith the inclusion of primary HPV testing in 2018 U.S. Preventive Services Taskforce guidelines, at-home HPV self-sampling may provide a...
-
Long-term risks of invasive cervical cancer following HPV infection: follow-up of two screening cohorts in Manchester
BackgroundLong-term follow-up of large cohorts is needed to determine the effects of HPV and screening on CIN3 (grade 3 cervical intraepithelial...
-
HPV-Induced Cancers
Highly prevalent human papillomavirus (HPV) can lead to cancer in the anogenital and oropharyngeal regions. Oncogenic, or high-risk, HPV types are...
-
Validation in Zambia of a cervical screening strategy including HPV genotyping and artificial intelligence (AI)-based automated visual evaluation
BackgroundWHO has recommended HPV testing for cervical screening where it is practical and affordable. If used, it is important to both clarify and...
-
Evaluation of DNA methylation biomarkers ASCL1 and LHX8 on HPV-positive self-collected samples from primary HPV-based screening
BackgroundHost-cell DNA methylation analysis can be used to triage women with high-risk human papillomavirus (HPV)-positive self-collected...
-
Prevalence and genotype distribution of HPV infections among women in Chengdu,China
BackgroundHuman papilloma virus (HPV) infection among female is the cause of cervical cancer and genital warts. In China, the HPV vaccination rate...
-
Prevailing of HPV-16 and 52 genotype in 2022–2023 in Sanandaj, Iran
IntroductionHuman papillomavirus (HPV) presents a potential threat to the onset of carcinogenesis in the cervix, anogenital regions, and oropharynx....
-
The prevalence of HPV among 164,137 women in China exhibited some unique epidemiological characteristics
ObjectiveThe persistence of HPV infection is a significant etiological factor in the development of cervical cancer. The present study investigated...
-
Verification of the association of the cycle threshold (Ct) values from HPV testing on Cobas4800 with the histologic grades of cervical lesions using data from two population-based cervical cancer screening trials
ObjectiveTo verify the association of high-risk human papillomavirus (hrHPV) viral load reflected by cycle threshold (Ct) values from HPV testing on...
-
Durability of single-dose HPV vaccination in young Kenyan women: randomized controlled trial 3-year results
Cervical cancer burden is high where prophylactic vaccination and screening coverage are low. We demonstrated in a multicenter randomized,...
